Kestra Medical Technologies, Ltd.KMTS stock score: 50/100
$26.63 · -5.87% · Scored Nov 19, 2026
- Technical
- 46
- Fundamental
- 51
- News
- 53
The reading
Kestra Medical Technologies (KMTS) scores 50 out of 100, which reads neutral, higher than 48% of Healthcare stocks and 46% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 51, technicals 46.
Among the fundamentals, Revenue Growth (5-Year) at 100 and Revenue Growth (Annual) at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 40 and contrarian oscillators 60.
News sentiment is neutral at 53; it is shown, not counted in the composite.
Since Aug 23, 2026 the composite has ranged from 42 to 54, and it is down 4 points over the period.
About Kestra Medical Technologies
Kestra Medical Technologies (KMTS) is a medical device company that makes the ASSURE system, a wearable cardioverter defibrillator. The vest-like garment is worn by patients at elevated but temporary risk of sudden cardiac arrest, such as those recovering from a heart attack, heart surgery or a new diagnosis of a weak heart muscle, while doctors decide on longer-term treatment. The device continuously monitors heart rhythm and can deliver a shock automatically if it detects a life-threatening arrhythmia, and it links to a monitoring platform used by clinicians. Kestra has studied the device in a large post-approval registry required by U.S. regulators and is working with Biobeat Technologies to add more diagnostic monitoring. Cardiologists and electrophysiologists prescribe the device, and Kestra earns money mainly by billing Medicare and private insurers for the period each patient wears it.
Kestra’s main competitor is ZOLL Medical, part of Asahi Kasei, whose LifeVest has long been the most widely used wearable defibrillator, and it also competes with implanted defibrillators for some patients. Its edge rests on a newer device designed for comfort and wearability, clinical data from routine practice and a growing sales force. Investors who follow KMTS stock tend to watch revenue growth and the number of prescriptions and active patients. Reimbursement rates and payer coverage are closely followed. Sales force expansion, gross margins, operating losses, cash use and new product features are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward KMTS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
51Pulling it up
5-year revenue growth analyzes long-term sales trajectory and consistency.
Annual revenue growth tracks year-over-year sales expansion.
How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.
Holding it back
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.
Operating margins measure profitability after operating expenses.
37 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
45Pulling it up
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
Where the close sits against its 100-day SMA.
Commodity Channel Index (14) measures how far price has moved from its average.
Holding it back
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
Stochastic (14) places the close within its 14-day high-low range.
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 53
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 34 | 1 |
| Daily | 45 | 3 |
| Weekly | 55 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 50 |
| Nov 18, 2026 | 52 |
| Nov 17, 2026 | 51 |
| Nov 16, 2026 | 51 |
| Nov 15, 2026 | 52 |
| Nov 14, 2026 | 52 |
| Nov 13, 2026 | 52 |
| Nov 12, 2026 | 51 |
| Nov 11, 2026 | 53 |
| Nov 10, 2026 | 51 |
| Nov 7, 2026 | 50 |
| Nov 6, 2026 | 50 |
| Nov 5, 2026 | 51 |
| Nov 4, 2026 | 53 |
| Nov 3, 2026 | 51 |
| Nov 2, 2026 | 52 |
| Nov 1, 2026 | 52 |
| Oct 30, 2026 | 52 |
| Oct 29, 2026 | 53 |
| Oct 27, 2026 | 53 |
| Oct 26, 2026 | 53 |
| Oct 25, 2026 | 52 |
| Oct 24, 2026 | 52 |
| Oct 23, 2026 | 53 |
| Oct 22, 2026 | 52 |
| Oct 21, 2026 | 51 |
| Oct 20, 2026 | 52 |
| Oct 19, 2026 | 52 |
| Oct 18, 2026 | 52 |
| Oct 17, 2026 | 52 |
| Oct 16, 2026 | 52 |
| Oct 15, 2026 | 52 |
| Oct 14, 2026 | 48 |
| Oct 13, 2026 | 52 |
| Oct 12, 2026 | 52 |
| Oct 11, 2026 | 52 |
| Oct 10, 2026 | 52 |
| Oct 9, 2026 | 52 |
| Oct 8, 2026 | 49 |
| Oct 7, 2026 | 51 |
| Oct 6, 2026 | 52 |
| Oct 5, 2026 | 53 |
| Oct 4, 2026 | 52 |
| Oct 3, 2026 | 52 |
| Oct 2, 2026 | 52 |
| Oct 1, 2026 | 52 |
| Sep 30, 2026 | 53 |
| Sep 29, 2026 | 53 |
| Sep 28, 2026 | 53 |
| Sep 27, 2026 | 53 |
| Sep 26, 2026 | 52 |
| Sep 25, 2026 | 52 |
| Sep 24, 2026 | 52 |
| Sep 23, 2026 | 52 |
| Sep 22, 2026 | 51 |
| Sep 21, 2026 | 49 |
| Sep 20, 2026 | 48 |
| Sep 19, 2026 | 48 |
| Sep 18, 2026 | 48 |
| Sep 17, 2026 | 48 |
| Sep 16, 2026 | 48 |
| Sep 15, 2026 | 46 |
| Sep 14, 2026 | 42 |
| Sep 13, 2026 | 44 |
| Sep 12, 2026 | 44 |
| Sep 11, 2026 | 44 |
| Sep 10, 2026 | 46 |
| Sep 9, 2026 | 49 |
| Sep 8, 2026 | 53 |
| Sep 7, 2026 | 52 |
| Sep 6, 2026 | 51 |
| Sep 5, 2026 | 52 |
| Sep 4, 2026 | 52 |
| Sep 2, 2026 | 54 |
| Sep 1, 2026 | 53 |
| Aug 31, 2026 | 53 |
| Aug 30, 2026 | 53 |
| Aug 29, 2026 | 53 |
| Aug 28, 2026 | 53 |
| Aug 27, 2026 | 52 |
| Aug 26, 2026 | 53 |
| Aug 25, 2026 | 52 |
| Aug 24, 2026 | 54 |
| Aug 23, 2026 | 54 |
Key facts
- Market cap
- $1.6B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Beta
- —
- Risk grade (1–10)
- 9
- Next earnings
- Dec 14, 2026
Medical Instruments & Supplies peers
| Company | Market cap | Score |
|---|---|---|
| WRBY Warby Parker | $3.0B | 59 |
| ATRC AtriCure | $2.8B | 58 |
| AZTA Azenta | $2.0B | 49 |
| LMAT LeMaitre Vascular | $1.7B | 65 |
| XRAY DENTSPLY SIRONA | $1.7B | 46 |
| STAA STAAR Surgical Company | $1.3B | 53 |
All Medical Instruments & Supplies stocks, highest-scored first
Questions
What is KMTS's stock rating today?
KMTS scores 50/100 (Neutral) as of Nov 19, 2026: technical 46, fundamental 51, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.
What does Kestra Medical Technologies do?
Kestra Medical Technologies (KMTS) is a medical device company that makes the ASSURE system, a wearable cardioverter defibrillator. The vest-like garment is worn by patients at elevated but temporary risk of sudden cardiac arrest, such as those recovering from a heart attack, heart surgery or a new diagnosis of a weak heart muscle, while doctors decide on longer-term treatment.
Is KMTS stock a buy?
The score is not a buy or sell recommendation. A 50 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the KMTS score calculated?
99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 3 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/kmts/"><img src="https://stocksscores.com/stocks/kmts/badge.svg" alt="KMTS stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/kmts/)